Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Neuroimmunology & Neuroinflammation
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

Share

August 2016; 3 (4) Clinical/Scientific NotesOpen Access

Delayed diagnosis of extraovarian teratoma in relapsing anti-NMDA receptor encephalitis

Tania Kümpfel, Lisa Ann Gerdes, Clarissa Heck, Harald Prüss
First published June 16, 2016, DOI: https://doi.org/10.1212/NXI.0000000000000250
Tania Kümpfel
From the Institute of Clinical Neuroimmunology (T.K., L.A.G.), Ludwig-Maximilians University, Munich; and Charité Universitätsmedizin Berlin and German Center for Neurodegenerative Diseases (DZNE) Berlin (C.H., H.P.), Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Ann Gerdes
From the Institute of Clinical Neuroimmunology (T.K., L.A.G.), Ludwig-Maximilians University, Munich; and Charité Universitätsmedizin Berlin and German Center for Neurodegenerative Diseases (DZNE) Berlin (C.H., H.P.), Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clarissa Heck
From the Institute of Clinical Neuroimmunology (T.K., L.A.G.), Ludwig-Maximilians University, Munich; and Charité Universitätsmedizin Berlin and German Center for Neurodegenerative Diseases (DZNE) Berlin (C.H., H.P.), Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harald Prüss
From the Institute of Clinical Neuroimmunology (T.K., L.A.G.), Ludwig-Maximilians University, Munich; and Charité Universitätsmedizin Berlin and German Center for Neurodegenerative Diseases (DZNE) Berlin (C.H., H.P.), Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Delayed diagnosis of extraovarian teratoma in relapsing anti-NMDA receptor encephalitis
Tania Kümpfel, Lisa Ann Gerdes, Clarissa Heck, Harald Prüss
Neurol Neuroimmunol Neuroinflamm Aug 2016, 3 (4) e250; DOI: 10.1212/NXI.0000000000000250

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1346

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Anti–NMDA receptor (NMDAR) encephalitis is an autoimmune-mediated disease with a wide range of neurologic and psychiatric symptoms including psychosis, cognitive deficits, movement disorders, and epileptic seizures.1,2

Up to 50% of patients have tumors, mainly ovarian teratomas.1,2 We describe a 15-year-old girl with a relapsing course of severe and prolonged NMDAR encephalitis in whom an infrathyreodal teratoma was identified with FDG-PET-CT 14 months after symptom onset.

Case report.

A 15-year-old girl had been admitted to a local hospital due to ongoing fever and headache as well as abnormal behavior and irritability in March 2014. Subsequently she developed psychosis with visual hallucinations, delirium, fluctuating levels of consciousness, and epileptic seizures as well as dysautonomia with bradycardia. She was referred to our intensive care unit in April 2014 due to 4 episodes of cardiac arrest requiring a transient pacemaker and mechanical ventilation. Cerebral MRI was normal and CSF analysis showed no evidence of viral or bacterial infection. After she tested positive for high-titer NMDAR antibodies (Abs) in serum (immunoglobulin G [IgG] 1:320, immunoglobulin A [IgA] 1:100) and CSF (IgG 1:32, IgA 1:32), IV high-dose glucocorticosteroid and immunoglobulin therapy was initiated. She slowly started to improve after escalating immunotherapy with plasma exchange (PLEX) and subsequent treatment with rituximab (2 × 1 g). Ultrasound and MRI scan of the pelvis showed no evidence of ovarian teratoma. NMDAR Abs dropped significantly in serum and CSF after PLEX, but fluctuated over time. She experienced a relapse 2 months later with increasingly aggressive behavior and excessive hyperphagia with weight gain. Another PLEX was performed in July 2014 and rituximab continued with another cycle of 500 mg in December 2014. She improved thereafter and was discharged to a rehabilitation hospital. Reassessment in June 2015 still showed significant cognitive dysfunction and NMDAR Abs were again clearly detectable in serum (IgG 1:100, IgA 1:10) and CSF (IgG 1:3.2, IgA 1:10). Therefore, another diagnostic workup for possible tumor with whole-body FDG-PET-CT was performed and revealed a cystic mass with calcifications and fatty tissue inferior to the left thyroid gland suggesting teratoma (figure, A and B). Serum levels of β–human chorionic gonadotropin (β-HCG) and α-fetoprotein (AFP) were unremarkable. Diagnosis of teratoma was confirmed histopathologically after tumor removal without evidence of malignancy (figure, C and D). Therapy with rituximab was repeated and the patient was able to return to school.

Figure.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure. Patient imaging

(A, B) CT scan shows a tumor with calcifications and fatty tissue inferior to the left thyroid gland (arrows). (C) Histologic analysis reveals a mature teratoma containing cartilage, fatty tissue, glands, and hair follicles. (D) Some areas contained dense lymphocyte infiltrates, which are common in NMDA receptor encephalitis–associated teratomas.3 (E) Atypical neuronal elements in the teratoma detected with NeuN immunohistochemistry. (F, G) A similar neuronal staining was seen when sections were incubated with either a commercial anti-NR1 antibody (F) or CSF of a patient with high-titer NMDAR antibodies after immunoglobulin fluorescence labeling (G). For this, CSF was conjugated with N-hydroxysuccinimide-ester of Alexa Fluor 594 (Life Technologies, Carlsbad, CA) as described previously.2

Paraffin-embedded teratoma tissue was stained with CSF of a patient with high-titer NMDAR antibodies after fluorescence labeling of immunoglobulins.2 The teratoma contained neuronal elements detectable with immunohistochemistry for the neuronal protein NeuN, which were also immunopositive when probed with a commercial anti-NR1 antibody and the labeled CSF on adjacent sections (figure, E–G).3 Written informed consent was obtained from the parents according to the Declaration of Helsinki, and immunologic blood and CSF investigations approved by the local ethics committee.

Discussion.

The association of NMDAR encephalitis with teratomas is well-known, usually found in the ovaries or testis. It has become common practice to restrict the exclusion of a tumor in women with NMDAR encephalitis to ultrasound and MRI scans of the pelvis as extragonadal teratomas are exceptionally rare and FDG-PET-CTs are performed restrictively to avoid radiation in female adolescents. Extragonadal teratomas may occur in the head, neck, thyroid, and mediastinum.4 A large mediastinal teratoma was reported in a male adolescent with severe and prolonged NMDAR encephalitis who started to improve after resection of the teratoma and with immunosuppressive therapy.5

Serum levels of β-HCG and AFP may serve as additional disease markers indicating the presence of an undetected teratoma, although they may not be evident at diagnostic workup, as in our case. Recently the presence of CSF IgA NMDAR Abs has been described as a potential biomarker for ovarian teratomas.6 Indeed, positive testing of CSF IgA NMDAR Abs together with persisting cognitive dysfunction prompted us to perform an extensive tumor search including FDG-PET-CT.

Rapid detection of a teratoma is important since clinical improvement is linked to removal and prevents ongoing disease activity as well as relapses.7 In fact, only after surgical removal was sustained improvement of NMDAR encephalitis–associated symptoms achieved in our patient. The demonstrated binding of CSF immunoglobulins to neuronal elements in the teratoma suggests that this extraovarian tumor triggered and sustained the NMDAR encephalitis.

This case illustrates 2 important points in NMDAR encephalitis: (1) exclusion of ovarian teratomas with MRI or ultrasound is not sufficient in some patients as extragonadal teratomas may occur; and (2) tumors should be considered in patients with a prolonged relapsing disease course and persistent CSF NMDAR antibody titers, including the IgA isotype.

Footnotes

  • Study funding: No targeted funding.

  • Disclosures: T. Kümpfel received travel funding and speaker honoraria from Teva, Merck-Serono, Genzyme, Novartis Pharma, and Biogen Idec. L.A. Gerdes served on the advisory board for Genzyme, received travel support and/or speaker honoraria from Biogen and Bayer Schering, and received research support from Gemeinnutzige Hertie Stiftung. C. Heck and H. Pruess report no disclosures. Go to Neurology.org/nn for full disclosure forms. The Article Processing Charge was paid by the Institute of Clinical Neuroimmunology, L M U-Munich.

  • Received March 21, 2016.
  • Accepted in final form May 6, 2016.
  • © 2016 American Academy of Neurology

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

References

  1. 1.↵
    1. Dalmau J,
    2. Gleichman AJ,
    3. Hughes EG, et al.
    Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091–1098.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Prüss H,
    2. Leubner J,
    3. Wenke NK, et al.
    Anti-NMDA receptor encephalitis in the Polar bear (Ursus maritimus) Knut. Sci Rep 2015;27:12805.
    OpenUrl
  3. 3.↵
    1. Day GS,
    2. Laiq S,
    3. Tang-Wai DF,
    4. Munoz DG
    . Abnormal neurons in teratomas in NMDAR encephalitis. JAMA Neurol 2014;71:717–724.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Alexander VR,
    2. Manjaly JG,
    3. Pepper CM, et al.
    Head and neck teratomas in children: a series of 23 cases at Great Ormond Street Hospital. Int J Pediatr Otorhinolaryngol 2015;79:2008–2014.
    OpenUrl
  5. 5.↵
    1. Sommeling C,
    2. Santens P
    . Anti-N-methyl-D-aspartate (anti-NMDA) receptor antibody encephalitis in a male adolescent with a large mediastinal teratoma. J Child Neurol 2014;29:688–690.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Desestret V,
    2. Chefdeville A,
    3. Viaccoz A, et al.
    CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis. Neurol Neuroimmunol Neuroinflamm 2015;2:e166. doi: 10.1212/NXI.0000000000000166.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Titulaer MJ,
    2. McCracken L,
    3. Gabilondo I, et al.
    Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157–165.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Preferences and User Experiences of Wearable Devices in Epilepsy A Systematic Review and Mixed-Methods Synthesis

Dr. Daniel Friedman and Dr. Sharon Chiang

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Autoimmune diseases

Alert Me

  • Alert me when eletters are published
Neurology - Neuroimmunology Neuroinflammation: 10 (2)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Neuroimmunology & Neuroinflammation
Online ISSN: 2332-7812

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise